|
gptkbp:instance_of
|
gptkb:vaccine
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:healthcare_organization
|
|
gptkbp:allows
|
Effectiveness
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:based_on
|
Immune response
|
|
gptkbp:can_be_used_with
|
Chemotherapy
Radiation therapy
|
|
gptkbp:caused_by
|
Side effects
|
|
gptkbp:developed_by
|
gptkb:physicist
|
|
gptkbp:focuses_on
|
Pharmaceutical research
Oncology research
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cancer Immunotherapy
|
|
gptkbp:improves
|
Survival rates
|
|
gptkbp:includes
|
gptkb:drug
Monoclonal antibodies
Cancer vaccines
Checkpoint inhibitors
|
|
gptkbp:is_associated_with
|
Quality of life improvements
Immune-related adverse events
|
|
gptkbp:is_characterized_by
|
Targeted action
|
|
gptkbp:is_discussed_in
|
Medical literature
|
|
gptkbp:is_enhanced_by
|
Innovative research
|
|
gptkbp:is_evaluated_by
|
Peer-reviewed studies
|
|
gptkbp:is_influenced_by
|
Tumor microenvironment
Tumor genetics
|
|
gptkbp:is_linked_to
|
Biomarker discovery
|
|
gptkbp:is_often_associated_with
|
Other treatment modalities
|
|
gptkbp:is_part_of
|
Precision medicine
Clinical guidelines
|
|
gptkbp:is_recognized_by
|
Health organizations
|
|
gptkbp:is_studied_in
|
Other diseases
|
|
gptkbp:is_supported_by
|
Patient advocacy groups
Biopharmaceutical companies
|
|
gptkbp:is_used_for
|
gptkb:Hematologic_cancers
Solid tumors
|
|
gptkbp:key
|
Cancer research
|
|
gptkbp:marketing_strategy
|
Cancer management
|
|
gptkbp:occupation
|
Medical science
|
|
gptkbp:origin
|
gptkb:New_technologies
|
|
gptkbp:personal_life
|
Genetic profiling
|
|
gptkbp:receives_funding_from
|
Government grants
|
|
gptkbp:regulates
|
Health authorities
|
|
gptkbp:requires
|
Patient monitoring
|
|
gptkbp:research
|
Clinical trials
|
|
gptkbp:resulted_in
|
gptkb:healthcare_organization
gptkb:Melanoma
Lung cancer
|
|
gptkbp:serves
|
gptkb:healthcare_organization
|
|
gptkbp:subject
|
gptkb:Public_interest
Conferences
|
|
gptkbp:technique
|
Cancer treatment
|
|
gptkbp:training
|
Medical schools
|
|
gptkbp:treatment
|
Metastatic cancer
|
|
gptkbp:type_of
|
Biological therapy
|
|
gptkbp:uses
|
Immune system
|